Skip to content

News & calendar

news: as of 2026-10-07
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-13

Tue · 13 Oct · today

Wed · 14 Oct

Behind

published · newest first

Thu · 9 Jul

partnership

12:30
Google News: Teva Pharmaceutical Industries Ltd.

Teva and Polpharma Biologics Announce Global Licensing

Teva and Polpharma Biologics announced a global licensing agreement.

Markets open original ↗

product

12:00
Google News: Enphase Energy, Inc.

Enphase's 20th anniversary PowerPack 1500 goes on pre-order

Enphase opened pre-orders for its new PowerPack 1500 battery, marking the company's 20th anniversary.

Markets open original ↗

regulation

10:00
Google News: Piramal Pharma Limited

Piramal Pharma Gains 2.5% as US FDA Closes Sellersville Site Inspection

Piramal Pharma shares gained after the US FDA closed its inspection of the Sellersville site.

Markets open original ↗

earnings

09:37
Google News: Momentus Inc.

MNTS Q1 2026 Earnings: Continuing Losses as Revenue Remains Absent; Stock Drops 2.9%

Momentus reported continuing Q1 losses with no revenue, and shares dropped 2.9%.

Markets open original ↗

earnings

07:51
Google News: SCHOTT Pharma AG & Co. KGaA

Schott Pharma jumps to highest since Oct 2025 on guidance boost, Q3 beat

Schott Pharma shares jumped to their highest level since October 2025 after a Q3 earnings beat and raised guidance.

Markets open original ↗

The wire

everything that arrived · 7 days